Black Diamond Therapeutics Inc

Black Diamond Therapeutics Inc

BDTX

Get informed when a big investor buys or sells

+ Follow
Market Cap$102.57M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Black Diamond Therapeutics IncBlack Diamond Therapeutics Inc-2.4--41%-0.1
$6.37

Current Fair Value

261.8% upside

Undervalued by 261.8% based on the discounted cash flow analysis.

Share Statistics

Market cap$102.57 Million
Enterprise Value$86.59 Million
Dividend Yield$- (-)
Earnings per Share$0.39
Beta3.25
Outstanding Shares57,233,413

Return

Return on Equity-41.43%ROE
Return on Assets-32.51%
Return on Invested Capital-38.79%

Valuation & Multiples

P/E Ratio-2.36P/E Ratio
PEG2.03PEG
Price to Sales-Price to Sales
Price to Book Ratio1.76Price to Book Ratio
Enterprise Value to Revenue-
Enterprise Value to EBIT-1.89
Enterprise Value to Net Income-3
Total Debt to Enterprise0.16
Debt to Equity0.14Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
May 13, 2026
EPS Estimate
$-0.20
Average shareholder expectation
Revenue Estimate
-
Average shareholder expectation

Next Earnings Call

Expected Date
August 6, 2026
EPS Estimate
$-0.18
Average shareholder expectation
Revenue Estimate
-
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio1.8203 139.73%
Total Calls56,200 75.39%
Total Puts102,300 5.90%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %67.29% 0.47%
Total Invested$82.03M 10.86%
Investors Holding108 2.00%

ESG Score

No data

About Black Diamond Therapeutics Inc